Lowering morning blood sugar levels, also known as fasting blood sugar, is crucial for managing diabetes and reducing the risk of complications. Here are five therapeutic agents commonly used to lower morning blood sugar:
Metformin:
Metformin is often the first-line medication for the treatment of type 2 diabetes. It works primarily by reducing glucose production in the liver and improving insulin sensitivity in peripheral tissues. Metformin is typically taken once or twice daily with meals and can help lower both fasting and postprandial (after-meal) blood sugar levels.
SGLT2 Inhibitors:
Sodium-glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin (Jardiance), dapagliflozin (Farxiga), and canagliflozin (Invokana), are a class of medications that work by increasing glucose excretion in the urine. They can lower both fasting and postprandial blood sugar levels and have been shown to provide cardiovascular and kidney benefits in people with type 2 diabetes.
GLP-1 Receptor Agonists:
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as liraglutide (Victoza), dulaglutide (Trulicity), and semaglutide (Ozempic), are injectable medications that mimic the action of GLP-1, a hormone that stimulates insulin secretion and reduces glucagon secretion. GLP-1 receptor agonists can lower fasting and postprandial blood sugar levels, promote weight loss, and have cardiovascular benefits.
Insulin:
For people with type 1 diabetes or advanced type 2 diabetes, insulin therapy may be necessary to lower morning blood sugar levels adequately. Long-acting insulin analogs, such as insulin glargine (Lantus) and insulin detemir (Levemir), are commonly used to provide basal insulin coverage and help stabilize fasting blood sugar levels. Some people may also require short-acting insulin before meals to control postprandial blood sugar levels.
World's Best Selling Women High Demand Products [Recommended]
- LactiFresh Gel - Female Intimate Care
- Bravona Forte - Breast Enhancemen
- NuviaLab Meno - Menopause
- Revamin Acne Cream - Acne
- Revamin Stretch Mark - Stretch Marks
- Prenatalin - Prenatal Care
- Eyevita Plus - Eye Health
- Night Mega Burner - Weight Loss
- Femin Plus - Female Libido
- NuviaLab Female Fertility - Fertility
- NuviaLab Sugar Control - Blood Sugar
- Dentolan - Fresh Breath
- NuviaLab Flex - Joint Health
- Lipid Control Plus - Cholesterol
- NuviaLab Relax - Stress
- Restilen - Stress
- Thyrolin - Thyroid
- Snoran Plus - Snoring
- NuviaLab Immune - Immunity
- ProBreast Plus - Breast Enhancement
- Meltamin - Weight Loss
- Matcha Extreme - Weight Loss
- Fat Burn Active - Weight Loss
DPP-4 Inhibitors:
Dipeptidyl peptidase-4 (DPP-4) inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), and linagliptin (Tradjenta), are oral medications that work by inhibiting the enzyme DPP-4, which degrades incretin hormones like GLP-1. By increasing incretin hormone levels, DPP-4 inhibitors can stimulate insulin secretion and reduce fasting and postprandial blood sugar levels.
These therapeutic agents can be used alone or in combination with other diabetes medications, depending on individual treatment goals, preferences, and medical history. It's essential to work closely with a healthcare provider to determine the most appropriate treatment plan for managing morning blood sugar levels and overall diabetes care.
Advertisement:
Collagen Select - Anti-Aging - Complete Review Here
Above product is world's best selling skincare product.
